The groundbreaking treatment of the medication represents a major breakthrough in the care of the condition. Different to existing drugs, tirzepatide impacts two pathways – glucagon-like peptide-1 (GLP-1) and the GIP https://tirzepatidepeptide065611.activablog.com/40965647/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment